1. Improve utilization & adherence to GL recommended therapies in CV prevention.

2. Improve identification and treatment of FH.

3. Improve use of partnerships and registries for care.



Session date: 
12/07/2018 - 12:00pm to 1:00pm CST
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Laurence S. Sperling, MD, FACC, FAHA, FACP, FASPC